Wellington Shields & Co. LLC trimmed its stake in Express Scripts Holding Co (NASDAQ:ESRX) by 21.0% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 32,535 shares of the company’s stock after selling 8,626 shares during the quarter. Express Scripts makes up 1.7% of Wellington Shields & Co. LLC’s holdings, making the stock its 15th largest holding. Wellington Shields & Co. LLC’s holdings in Express Scripts were worth $3,091,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds have also modified their holdings of the company. TRUE Private Wealth Advisors purchased a new position in shares of Express Scripts during the third quarter valued at $115,000. Palo Capital Inc. purchased a new position in shares of Express Scripts during the third quarter valued at $124,000. Landaas & Co. WI ADV purchased a new position in Express Scripts in the second quarter valued at about $102,000. Kaizen Advisory LLC grew its stake in Express Scripts by 147.6% in the second quarter. Kaizen Advisory LLC now owns 1,342 shares of the company’s stock valued at $104,000 after purchasing an additional 800 shares in the last quarter. Finally, Adviser Investments LLC grew its stake in Express Scripts by 321.9% in the second quarter. Adviser Investments LLC now owns 1,481 shares of the company’s stock valued at $114,000 after purchasing an additional 1,130 shares in the last quarter. Institutional investors and hedge funds own 84.20% of the company’s stock.
In other Express Scripts news, Director Mahon Thomas P. Mac sold 5,234 shares of the business’s stock in a transaction dated Wednesday, November 7th. The stock was sold at an average price of $99.50, for a total value of $520,783.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 0.79% of the stock is owned by insiders.
ESRX has been the topic of a number of recent research reports. Cowen restated a “buy” rating and issued a $88.00 target price on shares of Express Scripts in a research note on Friday, November 2nd. Credit Suisse Group downgraded Express Scripts from an “outperform” rating to a “neutral” rating and boosted their target price for the company from $90.00 to $96.50 in a research note on Tuesday, September 18th. BidaskClub upgraded Express Scripts from a “hold” rating to a “buy” rating in a research note on Tuesday, September 18th. Maxim Group restated a “hold” rating on shares of Express Scripts in a research note on Thursday, November 1st. Finally, Royal Bank of Canada boosted their target price on Express Scripts to $94.00 and gave the company an “outperform” rating in a research note on Monday, August 27th. Two investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. Express Scripts has a consensus rating of “Hold” and an average target price of $89.07.
Shares of NASDAQ:ESRX opened at $98.48 on Friday. Express Scripts Holding Co has a fifty-two week low of $59.17 and a fifty-two week high of $100.43. The stock has a market capitalization of $56.09 billion, a price-to-earnings ratio of 13.87, a P/E/G ratio of 1.25 and a beta of 0.89. The company has a quick ratio of 0.65, a current ratio of 0.77 and a debt-to-equity ratio of 0.63.
Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings results on Wednesday, October 31st. The company reported $2.43 earnings per share for the quarter, topping analysts’ consensus estimates of $2.42 by $0.01. Express Scripts had a return on equity of 25.43% and a net margin of 4.83%. The company had revenue of $25.56 billion during the quarter, compared to analysts’ expectations of $25.11 billion. During the same quarter in the previous year, the firm earned $2.51 earnings per share. The business’s quarterly revenue was up 3.6% compared to the same quarter last year. As a group, analysts predict that Express Scripts Holding Co will post 9.08 EPS for the current fiscal year.
About Express Scripts
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Featured Story: What are Institutional Investors?
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.